Complement System in Alzheimer's Disease

Akash Shah1, Uday Kishore2, Abhishek Shastri3

  • 1Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AD, UK.

Insights

The complement system, part of the immune system, plays a dual role in the brain. While essential for CNS function, its overactivation contributes to neuroinflammation in Alzheimer's disease.

Area of Science:

  • Neuroscience
  • Immunology
  • Molecular Biology

Background:

  • Alzheimer's disease is a progressive neurodegenerative disorder impacting memory and daily activities.
  • The complement system is a crucial innate immune component with over thirty proteins and three activation pathways.
  • This system is vital for central nervous system (CNS) functions like neurogenesis and synaptic plasticity.

Purpose of the Study:

  • To explore the dual role of the complement system in CNS function and neuroinflammation.
  • To investigate the complement system's contribution to neurodegenerative diseases, specifically Alzheimer's disease.
  • To identify potential therapeutic targets within the complement system to mitigate neuroinflammation.

Main Methods:

  • Literature review and synthesis of existing research on the complement system and Alzheimer's disease.
  • Analysis of the complement system's involvement in both normal CNS functioning and pathological processes.
  • Discussion of therapeutic strategies targeting complement-mediated neuroinflammation.

Main Results:

  • The complement system is integral to normal CNS processes, including synaptic pruning and neuronal plasticity.
  • Chronic activation of the complement system leads to neuroinflammation, a key factor in Alzheimer's disease pathogenesis.
  • Dysregulation of the complement cascade contributes significantly to the progression of neurodegenerative conditions.

Conclusions:

  • The complement system's intricate role in the CNS presents a complex challenge in treating Alzheimer's disease.
  • Targeting specific components of the complement pathway offers a promising therapeutic avenue to reduce neuroinflammation.
  • Further research is needed to fully elucidate and leverage the complement system for therapeutic benefit in neurodegeneration.

Related Concept Videos

Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
3.3K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
723
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
287